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Abstract 
Apoptosis is one of the most widely studied fields in biology and accounts for 
over 2% of all life science publications annually. It plays a fundamental role in 
development, and defects in the regulation of apoptosis are directly implicated in 
numerous well-known diseases including cancer, neurodegenerative disorders, 
tissue atrophy and auto-immune diseases. However, the field of apoptosis has 
humble beginnings and was neglected by biologists for much of its history. This 
chapter reviews the history of research in apoptosis and highlights key 
experiments that have contributed significantly to our current understanding of 
apoptosis. In addition, the topics covered in later chapters are briefly introduced. 
Introduction 
One of the most widely researched fields in biology since the early 1990s has 
been the study of apoptosis, a form of programmed cell death. Apoptosis was 
first defined as a collection of morphological events distinct from necrosis that 
were observed in a diverse range of cells and tissues undergoing cell death. These 
included cellular events such as cell shrinkage, membrane ruffling (known as 
blebbing) and packaging of the dying cell into small membrane-bound vesicles 
called apoptotic bodies. A variety of nuclear events were also observed that 
include chromatin condensation and nuclear fragmentation (Figure 1) [1]. 
Biochemical events specific to apoptosis were discovered later, including 
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degradation of DNA into regular-sized fragments [2] and exposure of a lipid 
called phosphatidylserine on the surface of apoptotic cells [3]. 
     These changes in morphology and biochemistry result in cell death, and in 
healthy adult humans around 10 million cells undergo apoptosis daily. Normal 
tissue homoeostasis and function depends on correct levels of apoptosis to 
counteract the increase in cell numbers due to cell proliferation and also to 
eliminate damaged or defective cells. It is a critical event during virtually every 
stage of development from embryogenesis right through to adulthood. Most 
cells retain the ability to undergo apoptosis in response to a wide range of 
death-inducing stimuli. Consequently, the regulation of apoptosis is tightly 
controlled in cells and defects in apoptosis can give rise to a number of diseases, 
including cancer, neurodegenerative disorders and auto-immune disease [4]. 
1842 to 1972: defining ‘apoptosis’ 
Biology is littered with examples of major discoveries that drift back into 
obscurity because the importance of these discoveries was not fully 
appreciated at the time. The work done by Gregor Mendel on the inheritance 
of individual characteristics in the pea plant is perhaps the most widely known 
example. His work went unnoticed by the general scientific community for 
nearly 50 years even though he had independently worked out the laws of 
inheritance over 30 years before gene theory was developed [5]. However, no 
major field in biology has been rediscovered as often as the field of apoptosis, 
which has been independently described at least five separate times over a 
period of 100 years (Figure 2). 
     The term apoptosis was first used in 1972 to describe a form of cell death 
with markedly different morphology to necrosis [1]. However, the idea that cells 
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Figure 1. Apoptosis is a form of cell death with morphology distinct from necrosis 
Cells undergo a number of sequential changes in morphology when dying by apoptosis and these 
are outlined in this figure. The earliest identifiable change in morphology is when the refractive 
index of the cell changes under visible light. Cell shrinkage and condensation of the chromatin on 
the nuclear membrane occur next and are rapidly followed by nuclear fragmentation and plasma 
membrane blebbing. Apoptotic body formation is the final stage in apoptosis and the entire 
process is believed to take about 1 h in vivo. 
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2002 Brenner, S., Sulston, J. and Horvitz, R.; Nobel Prize in Physiology and Medicine 
2000 
1990–2000 Mechanisms and biochemistry of apoptosis elucidated 
1990 
1980 
1970 
1960 
1988 Vaux, D.L.; BCL-2 is first protein discovered involved in apoptosis 
1982 Horvitz, R.; Genetic control of PCD in C. elegans 
1980 Wyllie, A.H.; DNA fragmentation in apoptosis 
1976 Sulston, J.; PCD in C. elegans 
1972 Kerr, J.; Shrinkage necrosis is renamed as apoptisis and defined 
1969 Whitton, J.M.; Comparison of vertebrate and invertebrate developmental cell death 
1965 Kerr, J.; First paper on cell death called shrinkage necrosis 
1961 Bellairs, R.; Electron microscopy of cell death (apoptosis) 
1951 Glücksmann, A.; Cell death in vertebrate development 
1950 
1940 
1930 
1920 
1910 1914 Grüper, L.; Chromatolysis in tissues to counteract mitosis 
1908 Mechnikov, I.; Nobel Prize in Physiology and Medicine – Phagocytosis 
1906 Collins, R; Developmental neuronal cell death 
1900 
1890 
1880 
1870 
1860 
1872 Stieda, L.; Chondrocyte death 
1864 Weismann, A.; Cell death in pupating Diptera 
1858 Virchow, R.; Defines necrobiosis as natural cell death 
1889 Felix, W.; Cell death in healthy mammalian tissue 
1885 Flemming, W.; Defines chromatolysis, equivalent to apoptosis 
1850 
1840 
1830 
1820 
1810 
1842 Vogt, C.; Developmental cell death in toads 
1839 Schleiden, M. and Schwann, T.; Cell theory developed 
1800 
Figure 2. Timeline of apoptosis illustrating some of the major discoveries in the field 
of cell death 
Although the concept of natural cell death was first hypothesized in 1842, the first description of 
apoptosis was in 1885 when Walther Flemming described a form of cell death that he called 
chromatolysis. This was regularly described in the literature for the next 30 years, but the field 
of cell death shifted in focus to phagocytosis for much of the first half of the 20th century. In the 
1960s, scientists regained an interest in cell death and in 1972, apoptosis was defined for the first 
time by John Kerr. Interest in the field remained low until the late 1980s when it became clear 
that apoptosis played a key role in development and disease, and identification of Bcl-2 as an anti- 
apoptotic molecule marked the beginning of intensive research into the mechanisms of apoptosis 
throughout the 1990s. The impact that research into apoptosis had on other disciplines in bio- 
logy was formally recognized when three pioneers of apoptosis research in invertebrates were 
awarded the Nobel Prize in Medicine and Physiology in 2002. PCD, programmed cell death. 
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can die naturally is a relatively old one and was first postulated 130 years earlier in 
1842 by Carl Vogt after he studied development in toads. This observation 
was even more remarkable when one considers that Schleiden and Schwann 
established cell theory, which postulates that all living matter is composed 
of individual units or cells, only 3 years earlier in 1839. This makes the concept of 
natural cell death one of the oldest theories in cell biology [6]. In 1858 Rudolph 
Virchow described a natural form of cell death that was distinct from necrosis and 
called it necrobiosis [7]. The first clear morphological description of apoptosis 
appeared in 1885 by Walther Flemming. Drawings of cells in regressing ovarian 
follicles portrayed shrinkage of cells, chromatin condensation, nuclear fragmenta- 
tion and formation of apoptotic bodies, and Flemming named this natural cell 
death chromatolysis. These are all morphological hallmarks of apoptosis and 
chromatolysis was regularly reviewed in the literature for over 30 years [8]. 
Apoptosis continued to drift into and out of fashion throughout the first half of 
the 20th century until an influential review on cell death was published in 1951. 
In this, Glücksmann described karyorrhexis and karyopyknosis as distinct forms 
of cell death that we now know to be events associated with apoptosis. He also 
suggested that cell death plays an important role in embryogenesis and develop- 
ment of vertebrates [9]. Consequently, some pathologists regained an interest in 
the mechanisms of cell death, and in 1965, the Australian pathologist John F. Kerr 
observed an unusual form of cell death following ischaemic injury of liver tissue, 
where the constituents of cells appeared to remain intact within small vesicles. 
He used the term shrinkage necrosis to define this form of cell death and subse- 
quent studies using electron microscopy identified the earliest morphological 
events as condensation of the cytoplasm and the nuclear chromatin [10]. Kerr 
went on sabbatical to Aberdeen where he collaborated with Andrew Wyllie and 
Professor Alister Currie. During this time, they coined the term apoptosis to 
replace the term shrinkage necrosis and defined this particular form of cell death 
in a paper published in 1972 that is widely acknowledged as being a major land- 
mark in the field of biology [1]. 
1972 to 1982: the first decade in apoptosis research 
Researchers were initially unaware that apoptosis had been identified and 
described it on numerous occasions throughout the second half of the 19th 
century and also during the first half of the 20th century. Consequently, much 
of the early research simply repeated observations already made during the 
19th and 20th centuries. These papers demonstrated the important role of 
apoptosis in development and disease, but the results were often limited to 
descriptions of morphology. Studies based solely on morphology have severe 
limitations and the interest from the general biological community during this 
period remained quite low. There was a significant risk that the concept of 
apoptosis would fade into obscurity just as chromatolysis had done 70 years 
previously, but for a number of important developments in the field. 
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     Two experiments in particular were vital in maintaining an interest during 
this crucial first decade of research. First was the observation that DNA was 
degraded into nucleosomal-sized fragments during radiation-induced cell 
death [2]. This is due to an endogenous nuclease that is only activated in 
response to apoptotic stimuli and was identified 17 years later in 1997 [11]. 
The presence of a DNA ladder suggested that specific biochemical alterations 
occur in cells during apoptosis. Throughout the 1970s and 1980s work on the 
nematode worm Caenorhabditis elegans yielded the second key insight into 
apoptosis. C. elegans proved invaluable in the study of developmental cell 
death and painstaking analysis of the lineage of every cell in the adult worm 
demonstrated that exactly 131 of the 1090 somatic cells generated during 
development underwent programmed cell death. Both the lineage of each 
dying cell and the time that it underwent programmed cell death were highly 
reproducible, and these observations highlighted the tightly regulated nature 
of developmental cell death in C. elegans [12]. Mutants of C. elegans were 
characterized and genetic screening quickly led to the discovery that more than 
12 separate genes were involved in programmed cell death [13–15]. 
     The identification of these specific biochemical and genetic events during 
apoptosis sowed the seeds for the subsequent explosion in our understanding of 
apoptosis. The field quickly moved away from stagnant studies of cell mor- 
phology into mainstream experimental science. Eventually, apoptosis would 
become a centrepiece in two of the most important fields in modern biochem- 
istry, namely cell signalling and molecular biology. The identification of an 
oncogene called bcl-2 that appeared to function solely as an anti-apoptotic pro- 
tein in cells was a fundamental discovery that heralded the beginning of a peri- 
od of intensive research into the biochemical processes underlying apoptosis. 
bcl-2: the opening act 
bcl-2 was initially characterized as a proto-oncogene that enhanced 
transformation of human lymphoma cells [16] but further work demonstrated 
that over-expression of bcl-2 was found to increase the survival of 
haematopoietic cells by reducing the sensitivity to apoptosis. This made Bcl-2 
arguably the first protein identified to be involved in apoptosis [17]. Bcl-2 was 
also involved in a second landmark experiment in 1992 when it was shown that 
over-expression could also protect against developmental cell death in C. 
elegans [18]. The ramifications of this experiment were enormous. For decades, 
biologists had compared the similar morphology of programmed cell death in 
invertebrates with apoptosis in vertebrates and speculated that the two 
processes were similar [19]. This simple experiment was the first conclusive 
proof that apoptosis in vertebrates and programmed cell death in invertebrate 
were conserved through evolution, and finally allowed genetic discoveries 
made in C. elegans to be applied in the study of apoptosis in mammalian cells. 
The unification of invertebrate and vertebrate cell death models accelerated the 
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identification and characterization of many biochemical components of 
apoptosis in mammalian cells. 
Unravelling the apoptotic machinery 
The morphology of vertebrate and invertebrate cells undergoing apoptosis was 
similar regardless of the initial apoptotic signal. This suggested that a common 
apoptotic pathway that is activated in response to many different initial stimuli 
exists in cells. Previous studies with C. elegans in the 1980s had identified about 
12 different genes that were involved in apoptosis. Some mutations completely 
inhibited apoptosis, while others only inhibited clearance of apoptotic bodies by 
surrounding cells. One gene called Ced-3 was absolutely required for apoptosis 
and was eventually cloned in 1993. This gene was found to share sequence 
homology with the mammalian protease ICE (interleukin-1 -converting 
enzyme; caspase 1) [20]. Since then, 12 other human caspases have been described 
and many have been shown to play a pivotal role in apoptosis. Unlike most other 
proteases, caspases have very high substrate specificity. They usually only cleave 
target proteins at one or two conserved sites and are absolutely required for 
apoptosis in response to most stimuli. Initiator caspases detect apoptosis-inducing 
stimuli and activate effector caspases that proceed to cleave essential enzymes and 
structural proteins in cells in a hierarchal protease cascade (Figure 3). 
     The discovery that caspases are central components in apoptosis was due pri- 
marily to genetic studies in C. elegans. However, research with viruses identified 
an entirely new class of apoptosis regulators in mammalian cells that directly 
inhibit caspase activity and apoptosis by steric hindrance of caspase active sites. 
Some baculoviruses were shown to express a protein called IAP (inhibitor of 
apoptosis protein) that binds with caspases and inhibit caspase activity. Herpes 
virus was found to express another protein called v-FLIP (viral Flice-like 
inhibitory protein) that shares some sequence homology with caspase-8 and was 
found to inhibit only death-receptor-mediated apoptosis by binding with the 
FADD (Fas-associated death domain) in place of caspase-8. Cellular homologues 
of IAP and FLIP were quickly identified and these molecules are believed to play 
a crucial role in regulating the sensitivity of cells to apoptotic stimuli [21,22]. 
     The mitochondrion is particularly sensitive to many different apoptosis- 
inducing stimuli and dysfunction of mitochondria is associated with pore for- 
mation and mitochondrial membrane depolarization in cells. This is a 
reversible step, and mitochondria can repolarize and continue to generate ATP 
during the early stages of apoptosis. A number of proteins were identified in 
mitochondria that were released into the cytosol during pore formation. Some 
of these molecules function as molecular guillotines in the cytosol and are 
sequestered in mitochondria away from their cytoplasmic targets in healthy 
cells. One such molecule called cytochrome c is usually involved in oxidative 
phosphorylation in mitochondria. However, release of cytochrome c into the 
cytosol stimulates the formation of a multimeric complex called the apopto- 
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Figure 3. Caspases are central components in apoptosis 
Caspases are a family of 12 aspartate proteases that have limited substrate specificity. Initiator 
caspases detect cellular stress signals from different sources and include caspase-2, caspase-8, 
caspase-9, caspase-10 and caspase-12. These initiator caspases cleave and activate effector cas- 
pases either directly or indirectly. Effector caspases, including caspase-3, caspase-6 and caspase-7, 
cleave a variety of downstream target proteins. This illustration highlights the central role of cas- 
pases in response to different cellular stresses. 
some, where caspase-9 is recruited and can activate caspase-3 [23]. 
Cytochrome c release from mitochondria is regulated by Bcl-2 and this is 
believed to be the principal mode of action of the anti-apoptotic Bcl-2 family 
members [24]. Caspase-3, caspase-9 and Bcl-2 are homologous with Ced-3, 
Ced-4 and Ced-9 respectively in C. elegans and the conservation of this 
biochemical pathway helped illustrate the central role played by the mitochon- 
drion in apoptosis. 
Implicating apoptosis with disease 
As the components of apoptosis were identified, it soon became clear that defects 
in these proteins were often associated with a number of diseases. One year after 
the bcl-2 gene was cloned and characterized, a cell-surface receptor called Fas was 
discovered and was found to induce apoptosis and cause tumour regression when 
bound with anti-Fas monoclonal antibodies [25]. The gene that codes for Fas 
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receptor was subsequently cloned and was found to share sequence homology 
with tumour necrosis factor receptors 1 and 2 [26]. Mutations in Fas receptor 
were identified in a particular strain of mice with an autosomal recessive 
lymphoproliferative (lpr) disorder [27]. The authors concluded correctly that 
these mutations were the underlying cause of auto-immune disorders in lpr mice 
and this was the first clear indication that apoptosis may be a key regulator of the 
immune system function. As a result the concept of apoptosis was introduced for 
the first time to many researchers studying auto-immune disease, 
immunosuppression, immunotolerance and AIDS. 
     The tumour-suppressor protein p53 had first been observed in 1979, 
over a decade before Fas receptor had been identified. Subsequently, p53 was 
found to be mutated or absent in over half of all human carcinomas [28]. 
While it was known that p53 could regulate transcription, the main function 
of p53 was not identified until researchers discovered that it induces apopto- 
sis in response to DNA damage and defects in the cell cycle [29,30]. The 
prevalence of p53 mutations clearly demonstrated the importance of apopto- 
sis during tumorigenesis. Subsequent research identified defects in apoptosis 
in virtually every human cancer. 
Perspective: the rise and rise of apoptosis 
Research in apoptosis now encompasses many diverse biological disciplines 
from plant science to clinical science and accounts for more than 13 000 
publications annually [31]. It is remarkable that a field overlooked by the 
general scientific community for so long has become so important in our 
understanding of such a diverse range of biological processes. Early 
experiments identified key biochemical and genetic events and these were 
crucial for the subsequent explosion of research in apoptosis. Genetic studies in 
C. elegans contributed significantly to delineating the biochemical pathways in 
apoptosis during the 1990s. The scientific community formally acknowledged 
this when Sydney Brenner, John Sulston and Robert Horvitz shared the Nobel 
Prize in Physiology and Medicine in 2002. The Nobel Prize has arrived at an 
opportune time and heralds the beginning of a new era in apoptosis research. 
Defects in apoptosis have been attributed to many well-known incurable 
diseases. The most important question during the next decade of research will 
be how can we convert this new wealth of genetic and biochemical information 
into therapies that can prevent and cure these illnesses. 
Summary 
 Apoptosis was first defined in 1972, but the field of cell death is much 
older and was originally hypothesized in 1842. Early genetic and bio- 
chemical studies of apoptosis were essential in maintaining an interest 
in the nascent field. 
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 The first protein implicated in apoptosis was Bcl-2, when it was found 
that over-expression of Bcl-2 decreased apoptosis in haematopoietic 
cells. Bcl-2 was also shown to inhibit apoptosis in C. elegans demon- 
strating that evolution had conserved the mechanisms of apoptosis 
between invertebrates and vertebrates. 
 Cloning of the C. elegans gene Ced-3 allowed researchers to identify 
human counterparts by homology called caspases. Caspases were subse- 
quently shown to be central components of apoptosis in mammalian 
cells. 
 Two key regulators of caspases, called IAP and FLIP, were originally 
identified in viral DNA. Cellular homologues were quickly identified 
and were shown to regulate the sensitivity of cells to a number of cellu- 
lar insults. 
 Mitochondria play a pivotal role in detecting and amplifying apoptotic 
stimuli from nucleus, cytoplasm, endoplasmic reticulum and death 
receptors. Bcl-2 family members are believed to regulate apoptosis by 
increasing or decreasing the sensitivity of mitochondria to these apop- 
totic signals. 
 The importance of apoptosis in disease was highlighted when defects in 
Fas receptor and p53 were shown to give rise to lymphoproliferative 
disorders and tumorigenesis respectively. 
 Robert Horvitz, who made significant contributions to the field of devel- 
opmental apoptosis, was awarded the Nobel Prize in Physiology and 
Medicine in 2002. This represents the culmination of two decades of 
research into the genetic and biochemical processes involved in apoptosis. 
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